Trm140 has two recognition modes for 3-methylcytidine modification of the anticodon loop of tRNA substrates.

RNA

Department of Biochemistry and Biophysics, Center for RNA Biology, University of Rochester School of Medicine, Rochester, New York 14642, USA.

Published: March 2017

The 3-methylcytidine (mC) modification is ubiquitous in eukaryotic tRNA, widely found at C in the anticodon loop of tRNA, tRNA, and some tRNA species, as well as in the variable loop (V-loop) of certain tRNA species. In the yeast , formation of mC requires Trm140 for six tRNA substrates, including three tRNA species and three tRNA species, whereas in , two Trm140 homologs are used, one for tRNA and one for tRNA The occurrence of a single Trm140 homolog is conserved broadly among Ascomycota, whereas multiple Trm140-related homologs are found in metazoans and other fungi. We investigate here how Trm140 protein recognizes its six tRNA substrates. We show that Trm140 has two modes of tRNA substrate recognition. Trm140 recognizes G-U-tA of the anticodon loop of tRNA substrates, and this sequence is an identity element because it can be used to direct mC modification of tRNA However, Trm140 recognition of tRNA substrates is different, since their anticodons do not share G-U and do not have any nucleotides in common. Rather, specificity of Trm140 for tRNA is achieved by seryl-tRNA synthetase and the distinctive tRNA V-loop, as well as by tA and iA We provide evidence that all of these components are important in vivo and that seryl-tRNA synthetase greatly stimulates mC modification of tRNA and tRNA in vitro. In addition, our results show that Trm140 binding is a significant driving force for tRNA modification and suggest separate contributions from each recognition element for the modification.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5311504PMC
http://dx.doi.org/10.1261/rna.059667.116DOI Listing

Publication Analysis

Top Keywords

trna
21
trna substrates
20
trna trna
16
trna species
16
anticodon loop
12
loop trna
12
trm140
10
trm140 recognition
8
3-methylcytidine modification
8
trm140 trna
8

Similar Publications

The efficient isolation and molecular analysis of circulating tumor cells (CTCs) from whole blood at single-cell level are crucial for understanding tumor metastasis and developing personalized treatments. The viability of isolated cells is the key prerequisite for the downstream molecular analysis, especially for RNA sequencing. This study develops a laser-induced forward transfer -assisted microfiltration system (LIFT-AMFS) for high-viability CTC enrichment and retrieval from whole blood.

View Article and Find Full Text PDF

Glioblastoma (GBM) is described as a group of highly malignant primary brain tumors and stands as one of the most lethal malignancies. The genetic and cellular characteristics of GBM have been a focal point of ongoing research, revealing that it is a group of heterogeneous diseases with variations in RNA expression, DNA methylation, or cellular composition. Despite the wealth of molecular data available, the lack of transferable pre-clinic models has limited the application of this information to disease classification rather than treatment stratification.

View Article and Find Full Text PDF

Over the last decade, Hippo signaling has emerged as a major tumor-suppressing pathway. Its dysregulation is associated with abnormal expression of and -family genes. Recent works have highlighted the role of YAP1/TEAD activity in several cancers and its potential therapeutic implications.

View Article and Find Full Text PDF

Purpose: Mitoxantrone (MTX) is largely restricted in clinical usage due to its significant cardiotoxicity. Multiple studies have shown that an imbalance in the gut-heart axis plays an important role in the development of cardiovascular disease (CVD). We aim to explore the possible correlations between gut microbiota (GM) compositions and cardiometabolic (CM) disorder in MTX-triggered cardiotoxicity mice.

View Article and Find Full Text PDF

Diffuse alveolar hemorrhage (DAH) is a potentially life-threatening condition which can present with hemoptysis, diffuse alveolar infiltrates, anemia, and hypoxic respiratory failure. Antisynthetase syndrome (AS) is a rare autoimmune disorder most often characterized by nonerosive arthritis, proximal muscle weakness with elevated muscle enzymes, Raynaud's phenomenon, hyperkeratosis of the digits (mechanic's hands), and interstitial lung disease. According to large population studies, AS has an annual incidence of 0.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!